Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-09-182946
Filing Date
2009-08-27
Accepted
2009-08-27 16:09:04
Documents
10
Period of Report
2009-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 943725
2 FIFTH AMENDMENT EXPANSION AGREEMENT dex1036.htm EX-10.36 24519
3 SUBSIDIARIES OF THE COMPANY dex211.htm EX-21.1 2099
4 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM - ERNST & YOUNG LLP dex231.htm EX-23.1 1660
5 CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER dex311.htm EX-31.1 5968
6 CERTIFICATION OF THE CHIEF FINANCIAL OFFICER dex312.htm EX-31.2 6048
7 CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER dex321.htm EX-32.1 2891
8 CERTIFICATION OF THE CHIEF FINANCIAL OFFICER dex322.htm EX-32.2 2926
9 GRAPHIC g88217g07b73.jpg GRAPHIC 277716
10 GRAPHIC g88217g41q33.jpg GRAPHIC 76661
  Complete submission text file 0001193125-09-182946.txt   1479777
Mailing Address 300 AMERICAN ROAD MORRIS PLAINS NJ 07950
Business Address 300 AMERICAN RD MORRIS PLAINS NJ 07950 9736058200
IMMUNOMEDICS INC (Filer) CIK: 0000722830 (see all company filings)

EIN.: 611009366 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-K | Act: 34 | File No.: 000-12104 | Film No.: 091039701
SIC: 2835 In Vitro & In Vivo Diagnostic Substances